LOTTE Biologics Invests US$3.5 billion (₩4.6T) to Open New Bio Campus in Korea
Introduction:
LOTTE Biologics is investing US$3.5 billion (₩4.6 trillion) to construct a new Bio Campus in Songdo, Incheon, Korea.
Features:
This state-of-the-art facility, covering an impressive 202,285.2 square metres, will feature three advanced production plants along with essential auxiliary buildings.
Each plant is designed to have a production capacity of 120,000 litres, bringing the total capacity across the campus to 360,000 litres.
The scale of this project is underscored by its anticipated economic impact of 7.6 trillion won and the creation of 37,000 jobs, highlighting LOTTE Biologics' dedication to both industrial innovation and socioeconomic development.
This expansion is designed to place Korea at the forefront of the global bioeconomy and establish as a prominent leader in this crucial sector.
Specifications:
Name LOTTE Biologics
Type New Construction
Year 2028
